Main Article Content

Наталья Владимировна Артымук
Кристина Владимировна Марочко
Татьяна Юрьевна Марочко
Ольга Анатольевна Тачкова

Abstract

The aim of the research. To conduct an analytical review of modern sources of scientific literature covering the issues of premenstrual syndrome.

Materials and methods. The analysis of 42 foreign and domestic literature sources on this topic was carried out.

Results. About 70-80 % of women have PMS symptoms. The current understanding of the pathogenesis of PMS can be used in the treatment of both medicinal and herbal preparations. In the first-line treatment of PMS and PMDD, drospirenone-containing COCP are used. For maintenance therapy-preparations with herbal components.

Conclusion. Treatment should be carried out according to the form and severity of premenstrual disorder.

Keywords

premenstrual syndrome, premenstrual dysphoric disorder

Author Biographies

Наталья Владимировна Артымук,

Artymuk Natalia Vladimirovna
MD, PhD, professor, deputy editor of the journal Mother and Baby in Kuzbass.

She is the Head of the Department of Obstetrics and Gynaecology №2, the Deputy Editor-in-Chief. She is also the President of the Kemerovo regional public organization “Association of obstetricians and gynecologists”, the chief obstetrician-gynecologist of the Siberian Federal district; the member of the Board of the Russian Society of Obstetricians and Gynaecologists, the member of the European Society of Contraception and Reproductive Health, the European Society of Gynaecological Oncology and the International Society of Gynecological Endocrinology.

She has graduated from Kemerovo State Medical institute with honors. She studied in clinical residency in obstetrics and gynecology at School of Arenberg (Salzburg, Austria) and School of Bloomberg (Johns Hopkins University, Baltimore, USA). One is a specialist in ultrasound diagnostics in obstetrics and gynecology, endocrinology and endoscopic surgery. In 1996 in Barnaul she defended her PhD thesis and her doctoral thesis in 2003 in Moscow.

Her priorities are: endocrine gynecology, infertility, cervix uteri pathology, menopausal disorders, disorder of menstrual function, endoscopic and abdominal gynecological surgery.

She deals with reproductive health problems, non-surgical and surgical treatment of benign neoplasms of genital organs. She is an author of more than 450 scientific works, including 3 monographs and study manuals for doctors. She has her highest medical qualification category in “Obstetrics and gynecology”.

 
Кристина Владимировна Марочко,
candidate of medical sciences, assistant, department of the obstetrics and gynecology
Татьяна Юрьевна Марочко,
candidate of medical sciences, docent, department of the obstetrics and gynecology
Ольга Анатольевна Тачкова,
candidate of medical sciences, docent, department of the hospital therapy and clinical pharmacology

Article Details

Information about financing and conflict of interests

The study had no sponsorship.
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.

How to Cite

Артымук, Н. В., Марочко, К. В., Марочко, Т. Ю., & Тачкова, О. А. (2021). MODERN IDEAS ABOUT PREMENSTRUAL SYNDROME. LITERATURE REVIEW. Mother and Baby in Kuzbass, 22(1), 32-38. https://doi.org/10.24411/2686-7338-2021-10003

References

O'Brien PM, Bäckström T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011; 14(1): 13-21

Abubakirov AN, Adamyan LV, Aziev OV, Ailamazyan EK, Akulin IM, Andreeva VO et al. GYNECOLOGY. National leadership. M., 2017. Russian (Абубакиров А.Н., Адамян Л.В., Азиев О.В., Айламазян Э.К., Акулин И.М., Андреева В.О. и др. ГИНЕКОЛОГИЯ. Национальное руководство. М., 2017)

Solovieva AV, Radzinsky VE, Adamyan LV, Aleev IA, Apresyan SV, Artymuk NV et al. Guidelines for outpatient care in obstetrics and gynecology /ed. by VE Radzinsky. M., 2014. Russian (Соловьева А.В., Радзинский В.Е., Адамян Л.В., Алеев И.А., Апресян С.В., Артымук Н.В. и др. Руководство по амбулаторно-поликлинической помощи в акушерстве и гинекологии /под редакцией В.Е. Радзинского. М., 2014)

Hofmeister S, Bodden S. Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Am Fam Physician. 2016; 94(3): 236-240. PMID: 27479626

Gulieva LP, Yureneva SV. Premenstrual syndrome: clinical picture, diagnosis and therapeutic approaches. Medical Council. 2017; 2: 106-111. Russian (Гулиева Л.П., Юренева С.В.. Предменструальный синдром: клиника, диагностика и терапевтические подходы //Медицинский совет. 2017. № 2. С. 106-111.) 10.21518/2079-701X-2017-2-106-111

Serov VN, Tyutyunnik VL, Tverdikova MA. Premenstrual syndrome: tactics of managing patients in outpatient practice. Reproductive endocrinology. 2013; 4(12): 30-34. Russian (Серов В.Н., Тютюнник В.Л., Твердикова М.А. Предменструальный синдром: тактика ведения пациенток в амбулаторно-поликлинической практике //Репродуктивная эндокринология. 2013. № 4(12). С. 30-34)

Bäckström T, Bixo M, Johansson M, Nyberg S, Ossewaarde L, Ragagnin G, et al. Allopregnanolone and mood disorders. Prog Neurobiol. 2014; 113: 88-94

Steiner M, Pearlstein T. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment. J Clin Psychiatry. 2000; 61(12): 17-21

Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology. 2003; 28(3): 1-23

Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci. 2008; 33: 291-301

Wittchen HU, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002; 32(1): 119-132

Bäckström T, Andreen L, Birzniece V, Björn I, Johansson IM, Nordenstam-Haghjo M, et al. The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs. 2003; 17(5): 325-342

Potter J, Bouyer J, Trussell J, Moreau C. Premenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey. J Womens Health (Larchmt). 2009; 18(1): 31-39

Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology. 2003; 28(3): 55-99

Tschudin S, Bertea PC, Zemp E. Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample. Arch Womens Ment Health. 2010; 13(6): 485-494. DOI: 10.1007/s00737-010-0165-3

Banerjee N, Roy KK, Takkar D. Premenstrual dysphoric disorder – a study from India. Int J Fertil Womens Med. 2000; 45(5): 342-344

Issa BA, Yussuf AD, Olatinwo AW, Ighodalo M. Premenstrual dysphoric disorder among medical students of a Nigerian university. Ann Afr Med. 2010; 9(3): 118-122. DOI: 10.4103/1596-3519.68354

Green LJ, O’Brien PMS, Panay N, Craig M on behalf of the Royal College of Obstetricians and Gynecologists. Management of premenstrual syndrome. BJOG. 2017; 124: e73-e105. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg48/

Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health. 2006; 9(1): 41-49. DOI: 10.1007/s00737-005-0103-y

Nevatte T, O'Brien PM, Bäckström T, Brown C, Dennerstein L, Endicott J, et al. ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health. 2013; 16(4): 279-291. DOI: 10.1007/s00737-013-0346-y

American College of Obstetricians and Gynecologists. Guidelines for Women’s Health Care: A Resource Manual. 4th ed. Washington, DC: American College of Obstetricians and Gynecologists; 2014: 607-613

Spitzer R. DSM-IV-TR casebook. Washington DC: American Psychiatric Pub. 2002

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013

Steiner M. Recognition of premenstrual dysphoric disorder and its treatment. Lancet. 2000; 356(9236): 1126-1127

Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology. 2003; 28(3): 1-23

Pearlstein T, Steiner M. Non-antidepressant treatment of premenstrual syndrome. J Clin Psychiatry. 2000; 61(12): 22-27

Albsoul-Younes A, Alefishat E, Farha RA, Tashman L, Hijjih E, AlKhatib R. Premenstrual syndrome and premenstrual dysphoric disorders among Jordanian women. Perspect Psychiatr Care. 2018; 54(3): 348-353. DOI: 10.1111/ppc.12252

Zhang H, Zhu M, Song Y, Kong M. Baduanjin exercise improved premenstrual syndrome symptoms in Macau women. J Tradit Chin Med. 2014; 34(4): 460-464. DOI: 10.1016/s0254-6272(15)30047-9

Lustyk MK, Gerrish WG, Shaver S, Keys SL. Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health. 2009; 12(2): 85-96. DOI: 10.1007/s00737-009-0052-y

Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database of Systematic Reviews. 2012; (2): CD006586. DOI: 10.1002/14651858.CD006586.pub4

Verma RK, Chellappan DK, Pandey AK. Review on treatment of premenstrual syndrome: from conventional to alternative approach. J Basic Clin Physiol Pharmacol. 2014; 25(4). DOI: 10.1515/jbcpp-2013-0072

Adamyan LV, Absatarova YuS, Andreeva EN, Apolikhina IA, Artymuk NV, Bayramova GR et al. Gynecology. Pharmacotherapy without mistakes. A guide for doctors. M., 2020. Russian (Адамян Л.В., Абсатарова Ю.С., Андреева Е.Н., Аполихина И.А., Артымук Н.В., Байрамова Г.Р. и др. Гинекология. Фармакотерапия без ошибок. Руководство для врачей. М., 2020)

Adamyan LV, Artymuk NV, Ermakova OA. Formulary of medicines in obstetrics and gynecology. M., 2011. Russian (Адамян Л.В., Артымук Н.В., Ермакова О.А. Формуляр лекарственных средств в акушерстве и гинекологии. М., 2011)

Wyatt K, Dimmock P, O’Brien PMS. Premenstrual syndrome. Clin Evid. 2000; 4: 1121-1133

Kiselev VI, Smetnik VP, Suturina LV, Selivanov SP, Rudakova EB, Rakhmatullina IR et al. Indolcarbinol (Indinol Forto) – a method of multitarget therapy for cyclic mastodynia. Obstetrics and gynecology. 2013; 7: 56-63. Russian (Киселев В.И., Сметник В.П., Сутурина Л.В., Селиванов С.П., Рудакова Е.Б., Рахматуллина И.Р. и др. Индолкарбинол (Индинол Форто) – метод мультитаргетной терапии при циклической мастодинии //Акушерство и гинекология. 2013. № 7. С. 56-63)

Williams MJ, Harris RI, Dean BC. Controlled trial of pyridoxinein the premenstrual syndrome. J Int Med Res. 1985; 13: 174-179

Jang SH, Kim DI, Choi MS. Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review. BMC Complement Altern Med. 2014; 14: 11. DOI: 10.1186/1472-6882-14-11

Kim SC, Kim SN, Lim JA, Choi CM, Shim EK, Koo ST, et al. Effects of acupuncture treatment on the premenstrual syndrome: controlled clinical trial. J Korean A&M Soc. 2005; 22(1): 41-60

Habek D, Habek JČ, Barbir A. Using acupuncture to treat premenstrual syndrome. Arch Gynecol Obstet. 2002; 267: 23-26. DOI: 10.1007/s00404-001-0270-7

Shin KR, Young HJ, Park HJ, Heitkemper M. The effect of hand acupuncture therapy and hand moxibustion therapy on premenstrual syndrome among Korean women. West J Nurs Res. 2009; 31(2): 171-186

Dante G, Facchinetti F. Herbal treatments for alleviating premenstrual symptoms: a systematic review. J Psychosom Obstet Gynaecol. 2011; 32(1): 42-51. DOI: 10.3109/0167482X.2010.538102

Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol. 2009; 16(3): e407-429

Downloads

Download data is not yet available.

Most read articles by the same author(s)

<< < 1 2 3 4